» Articles » PMID: 38003847

Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease with a significant impact on quality of life. The overall goal of CRSwNP management, as with other chronic conditions, is to achieve "disease control", and for that reason, a definition of control of disease is pivotal in deciding the best treatment strategy. Although many staging systems have already been developed to evaluate the disease, disease control is not yet to be standardized, and a specific tool that is consistently applied and accepted by all practitioners is still missing in daily clinical practice. To gain an overview of the implementation and limitations of existing guidelines and to shed light on real-life definitions of control and disease severity, we conducted a nationwide survey of otorhinolaryngologists routinely treating CRSwNP to identify unmet clinical needs in Italy. The results showed homogeneous responses regarding the knowledge contained in international guidelines while highlighting the difficulty of their implementation in day-to-day practice. Respondents called attention to the importance of clinical symptoms, giving more weight to the patient's perspective. Among the symptoms to be considered, respondents emphasized nasal obstruction, followed by loss of sense of smell and rhinorrhea. Others also believe that the physician's perspective should be considered, and the inclusion of endoscopy as a measure of control was warranted by many. The need for a specific tool that is able to unequivocally ascertain disease control is increasingly pivotal in this new era of biologics for treating CRSwNP.

Citing Articles

Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey.

Anastasi F, Canevari F, Gallo S, Gramellini G, Heffler E, La Mantia I Front Allergy. 2025; 5():1519069.

PMID: 39840273 PMC: 11747549. DOI: 10.3389/falgy.2024.1519069.


Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains.

La Mantia I, Ottaviano G, Ragusa M, Trimarchi M, Foglia E, Schettini F J Pers Med. 2024; 14(4).

PMID: 38672974 PMC: 11051702. DOI: 10.3390/jpm14040347.

References
1.
Bhattacharyya N, Villeneuve S, Joish V, Amand C, Mannent L, Amin N . Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019; 129(9):1969-1975. PMC: 6767455. DOI: 10.1002/lary.27852. View

2.
Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I . Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020; 10:1. PMC: 6941282. DOI: 10.1186/s13601-019-0303-6. View

3.
Sedaghat A, Phillips K . Defining 'control' of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2023; 31(1):17-23. DOI: 10.1097/MOO.0000000000000858. View

4.
Stevens W, Schleimer R, Kern R . Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2016; 4(4):565-72. PMC: 4939220. DOI: 10.1016/j.jaip.2016.04.012. View

5.
Laidlaw T, Mullol J, Woessner K, Amin N, Mannent L . Chronic Rhinosinusitis with Nasal Polyps and Asthma. J Allergy Clin Immunol Pract. 2020; 9(3):1133-1141. DOI: 10.1016/j.jaip.2020.09.063. View